Rural Health
Resources by Topic: Illicit drug use
California County Fact Sheets: Treatment Gaps in Opioid-Agonist Medication Assisted Therapy (OA-MAT) and Estimates of How Many Additional Prescribers Are Needed
Presents county-level estimates of opioid use disorder rates and treatment needs in California. Features statistics including opioid overdose deaths, buprenorphine prescriptions, number of treatment programs, and estimates of buprenorphine-waivered prescribers.
Author(s): Lisa Clemans-Cope, Marni Epstein, Douglas A. Wissoker, Joshua Aarons
Date: 11/2019
Sponsoring organization: Urban Institute
view details
Presents county-level estimates of opioid use disorder rates and treatment needs in California. Features statistics including opioid overdose deaths, buprenorphine prescriptions, number of treatment programs, and estimates of buprenorphine-waivered prescribers.
Author(s): Lisa Clemans-Cope, Marni Epstein, Douglas A. Wissoker, Joshua Aarons
Date: 11/2019
Sponsoring organization: Urban Institute
view details
Characterizing the Rural Opioid Use Environment in Kentucky Using Google Earth: Virtual Audit
Presents a study on the reliability of using Google Earth to track physical environment data correlating with rural opioid use. Examines data drawn from 5 rural counties in Kentucky using Google Earth between 2017 and 2018.
Author(s): Natalie Danielle Crawford, Regine Haardörfer, Hannah Cooper, et al.
Citation: Journal of Medical Internet Research, 21(10), e14923
Date: 10/2019
view details
Presents a study on the reliability of using Google Earth to track physical environment data correlating with rural opioid use. Examines data drawn from 5 rural counties in Kentucky using Google Earth between 2017 and 2018.
Author(s): Natalie Danielle Crawford, Regine Haardörfer, Hannah Cooper, et al.
Citation: Journal of Medical Internet Research, 21(10), e14923
Date: 10/2019
view details
Obstetric Delivery Inpatient Stays Involving Substance Use Disorders and Related Clinical Outcomes, 2016
Presents statistics from the 2016 National Inpatient Sample (NIS) on delivery-related inpatient stays involving substance use disorders (SUDs). Types of SUDs reported include the use of opioids, cocaine, and other stimulants in urban and rural areas. Examines clinical outcomes at delivery including preterm delivery, severe preeclampsia/eclampsia, obstetric hemorrhage, and placental abruption. Compares delivery outcomes with or without SUD diagnosis, and by rural or urban residence of patient.
Author(s): Anita Soni, Kathryn R. Fingar, Lawrence D. Reid
Date: 10/2019
Sponsoring organizations: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project
view details
Presents statistics from the 2016 National Inpatient Sample (NIS) on delivery-related inpatient stays involving substance use disorders (SUDs). Types of SUDs reported include the use of opioids, cocaine, and other stimulants in urban and rural areas. Examines clinical outcomes at delivery including preterm delivery, severe preeclampsia/eclampsia, obstetric hemorrhage, and placental abruption. Compares delivery outcomes with or without SUD diagnosis, and by rural or urban residence of patient.
Author(s): Anita Soni, Kathryn R. Fingar, Lawrence D. Reid
Date: 10/2019
Sponsoring organizations: Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project
view details
The Providers
Collection of learning resources related to The Providers, a film which follows 3 healthcare providers employed at a group of safety-net clinics in northern New Mexico. Explores the physician shortage, health disparities, and the opioid epidemic in rural America. Geared toward high school and college students.
Date: 09/2019
Sponsoring organization: PBS Learning Media
view details
Collection of learning resources related to The Providers, a film which follows 3 healthcare providers employed at a group of safety-net clinics in northern New Mexico. Explores the physician shortage, health disparities, and the opioid epidemic in rural America. Geared toward high school and college students.
Date: 09/2019
Sponsoring organization: PBS Learning Media
view details
State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome
Identifies state strategies to improve outcomes for pregnant and postpartum women with opioid use disorder and infants prenatally exposed to substances, including opioids. Discusses strategies focused on access to and coordination of quality services, including approaches such as telemedicine that are useful in rural areas. Also discusses strategies related to provider awareness and training and other topics.
Author(s): Charlan D. Kroelinger, Marion E. Rice, Shanna Cox, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 68(36), 777-783
Date: 09/2019
Sponsoring organization: Centers for Disease Control and Prevention
view details
Identifies state strategies to improve outcomes for pregnant and postpartum women with opioid use disorder and infants prenatally exposed to substances, including opioids. Discusses strategies focused on access to and coordination of quality services, including approaches such as telemedicine that are useful in rural areas. Also discusses strategies related to provider awareness and training and other topics.
Author(s): Charlan D. Kroelinger, Marion E. Rice, Shanna Cox, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 68(36), 777-783
Date: 09/2019
Sponsoring organization: Centers for Disease Control and Prevention
view details
Dismantling Buprenorphine Policy Can Provide More Comprehensive Addiction Treatment
Commentary focused on the impact buprenorphine prescribing policy has on access to opioid addiction treatment. Discusses the lack of providers waivered to prescribe buprenorphine in rural areas. Includes a map showing counties that lack providers who can prescribe medications for opioid use disorder.
Author(s): Alex E. Woodruff, Mary Tomanovich, Leo Beletsky, et al.
Date: 09/2019
Sponsoring organization: National Academy of Medicine
view details
Commentary focused on the impact buprenorphine prescribing policy has on access to opioid addiction treatment. Discusses the lack of providers waivered to prescribe buprenorphine in rural areas. Includes a map showing counties that lack providers who can prescribe medications for opioid use disorder.
Author(s): Alex E. Woodruff, Mary Tomanovich, Leo Beletsky, et al.
Date: 09/2019
Sponsoring organization: National Academy of Medicine
view details
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison
Details a study on hepatitis C treatment and prevention interventions for people who use drugs in rural and urban areas. Compares the results of medication-assisted treatment (MAT) and syringe service program (SSP) interventions in rural Perry County, Kentucky and urban San Francisco, California.
Author(s): Hannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Citation: American Journal of Epidemiology, 188(8), 1539-1551
Date: 08/2019
view details
Details a study on hepatitis C treatment and prevention interventions for people who use drugs in rural and urban areas. Compares the results of medication-assisted treatment (MAT) and syringe service program (SSP) interventions in rural Perry County, Kentucky and urban San Francisco, California.
Author(s): Hannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Citation: American Journal of Epidemiology, 188(8), 1539-1551
Date: 08/2019
view details
Acceptability of Safe Drug Consumption Spaces among People Who Inject Drugs in Rural West Virginia
Presents a study on the acceptability of safe consumption spaces among people who inject drugs in rural West Virginia. Breaks down data by demographic data, overdoses, and drugs used, among other characteristics.
Author(s): Allison O'Rourke, Rebecca Hamilton White, Ju Nyeong Park, et al.
Citation: Harm Reduction Journal, 16, 51
Date: 08/2019
view details
Presents a study on the acceptability of safe consumption spaces among people who inject drugs in rural West Virginia. Breaks down data by demographic data, overdoses, and drugs used, among other characteristics.
Author(s): Allison O'Rourke, Rebecca Hamilton White, Ju Nyeong Park, et al.
Citation: Harm Reduction Journal, 16, 51
Date: 08/2019
view details
Factors that Influence Access to Medication-Assisted Treatment
Results of a study examining factors that influence access to medication-assisted treatment and substance use disorder treatment, including rural location, stigma, shortage of providers, and insurance coverage. Uses data from an electronic survey distributed to 59 State Opioid Treatment Authorities or Single State Authorities in the spring of 2019.
Additional links: Policy Brief
Author(s): Dana Foney, Shannon Mace
Date: 08/2019
Sponsoring organizations: National Council for Mental Wellbeing, University of Michigan Behavioral Health Workforce Research Center
view details
Results of a study examining factors that influence access to medication-assisted treatment and substance use disorder treatment, including rural location, stigma, shortage of providers, and insurance coverage. Uses data from an electronic survey distributed to 59 State Opioid Treatment Authorities or Single State Authorities in the spring of 2019.
Additional links: Policy Brief
Author(s): Dana Foney, Shannon Mace
Date: 08/2019
Sponsoring organizations: National Council for Mental Wellbeing, University of Michigan Behavioral Health Workforce Research Center
view details
Evidence Brief: Barriers and Facilitators to Use of Medications for Opioid Use Disorder
Report details an analysis of barriers and facilitators to administering medication-assisted treatment (MAT) for opioid use disorder (OUD) that are applicable to the Veterans Health Administration. Highlights a synthesis of data extracted from a number of selected studies from 2014-2019, as well as VA data from 2006-2019. Includes data focusing on rural areas.
Date: 08/2019
Sponsoring organization: Veterans Health Administration
view details
Report details an analysis of barriers and facilitators to administering medication-assisted treatment (MAT) for opioid use disorder (OUD) that are applicable to the Veterans Health Administration. Highlights a synthesis of data extracted from a number of selected studies from 2014-2019, as well as VA data from 2006-2019. Includes data focusing on rural areas.
Date: 08/2019
Sponsoring organization: Veterans Health Administration
view details